shRNA against ABCB5 or anti-ABCB5 mAb on G3361 melanoma cells decreased cancer cell survival to dacarbazine, paclitaxel, teniposide, docetaxel, etoposide, doxorubicin, and vincristine[53]. The gene discussed is ABCB5; the disease is cancer.